Menu
GeneBe

12-18293984-A-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001288772.2(PIK3C2G):c.1003A>C(p.Ser335Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000238 in 1,589,380 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00015 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00025 ( 1 hom. )

Consequence

PIK3C2G
NM_001288772.2 missense

Scores

1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.73
Variant links:
Genes affected
PIK3C2G (HGNC:8973): (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma) The protein encoded by this gene belongs to the phosphoinositide 3-kinase (PI3K) family. PI3-kinases play roles in signaling pathways involved in cell proliferation, oncogenic transformation, cell survival, cell migration, and intracellular protein trafficking. This protein contains a lipid kinase catalytic domain as well as a C-terminal C2 domain, a characteristic of class II PI3-kinases. C2 domains act as calcium-dependent phospholipid binding motifs that mediate translocation of proteins to membranes, and may also mediate protein-protein interactions. This gene may play a role in several diseases, including type II diabetes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
RERGL (HGNC:26213): (RERG like) Predicted to enable G protein activity and GTP binding activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.17054349).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PIK3C2GNM_001288772.2 linkuse as main transcriptc.1003A>C p.Ser335Arg missense_variant 5/33 ENST00000538779.6
LOC124902890XR_007063233.1 linkuse as main transcriptn.159+2998T>G intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PIK3C2GENST00000538779.6 linkuse as main transcriptc.1003A>C p.Ser335Arg missense_variant 5/335 NM_001288772.2 P1

Frequencies

GnomAD3 genomes
AF:
0.000151
AC:
23
AN:
152076
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000768
AC:
19
AN:
247402
Hom.:
0
AF XY:
0.0000745
AC XY:
10
AN XY:
134198
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000292
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000152
Gnomad OTH exome
AF:
0.000167
GnomAD4 exome
AF:
0.000247
AC:
355
AN:
1437304
Hom.:
1
Cov.:
25
AF XY:
0.000216
AC XY:
155
AN XY:
716506
show subpopulations
Gnomad4 AFR exome
AF:
0.0000303
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000288
Gnomad4 OTH exome
AF:
0.000672
GnomAD4 genome
AF:
0.000151
AC:
23
AN:
152076
Hom.:
0
Cov.:
32
AF XY:
0.000108
AC XY:
8
AN XY:
74286
show subpopulations
Gnomad4 AFR
AF:
0.0000483
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000309
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000268
Hom.:
0
Bravo
AF:
0.000125
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000246
AC:
2
ExAC
AF:
0.0000662
AC:
8
EpiCase
AF:
0.000600
EpiControl
AF:
0.000119

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 14, 2023The c.1003A>C (p.S335R) alteration is located in exon 5 (coding exon 4) of the PIK3C2G gene. This alteration results from a A to C substitution at nucleotide position 1003, causing the serine (S) at amino acid position 335 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.39
Cadd
Benign
17
Dann
Benign
0.97
DEOGEN2
Benign
0.19
T;.;T;T
Eigen
Benign
-0.44
Eigen_PC
Benign
-0.54
FATHMM_MKL
Benign
0.22
N
LIST_S2
Benign
0.74
T;T;T;.
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.17
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationTaster
Benign
1.0
N;N;N;N
PrimateAI
Benign
0.35
T
PROVEAN
Benign
0.15
N;N;N;N
REVEL
Benign
0.088
Sift
Benign
0.046
D;D;D;D
Sift4G
Uncertain
0.0080
D;T;T;T
Polyphen
0.51, 0.26
.;P;B;B
Vest4
0.47
MutPred
0.44
Gain of catalytic residue at S335 (P = 0.0043);Gain of catalytic residue at S335 (P = 0.0043);Gain of catalytic residue at S335 (P = 0.0043);Gain of catalytic residue at S335 (P = 0.0043);
MVP
0.41
MPC
0.013
ClinPred
0.12
T
GERP RS
1.8
Varity_R
0.11
gMVP
0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200790997; hg19: chr12-18446918; API